{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:55:55Z","timestamp":1790916955780,"version":"4.1.0"},"reference-count":43,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:00:00Z","timestamp":1790899200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To evaluate the outcome-specific incremental value of longitudinal clinical history and model complexity for annual dynamic prediction of multiple type 2 diabetes-related outcomes using pooled landmarking.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We included 646 patients with complete annual records from baseline through year 3. Landmark times at years 1 and 2 were used to predict the first recorded occurrence of hypertension, coronary heart disease, diabetic kidney disease, diabetic retinopathy, or metabolic dysfunction-associated steatotic liver disease during the subsequent year. Four progressively expanded feature sets were compared using elastic-net logistic regression and Light Gradient Boosting Machine. The primary history-current estimand was a paired within-algorithm contrast with the risk set, validation splits, preprocessing, tuning, calibration, and evaluation records held constant. Internal validation used patient-level repeated nested cross-validation. We also evaluated fully nested model selection and model-development stability using 500 patient-level bootstrap replicates with out-of-bag evaluation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Pooled out-of-fold area under the receiver operating characteristic curve ranged from 0.722 to 0.952 across the five representative models. The paired history-current comparison showed higher AUC for hypertension with elastic-net (\u0394AUC 0.097, 95% confidence interval 0.057 to 0.136) and LightGBM (0.118, 0.081 to 0.158), and for metabolic dysfunction-associated steatotic liver disease with elastic-net (0.022, 0.002 to 0.042) and LightGBM (0.025, 0.009 to 0.041). The other three outcomes showed no comparable improvement. Algorithm differences were modest and outcome dependent.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In this single-center cohort with complete annual T0\u2013T3 follow-up, the incremental value of longitudinal information and model complexity was outcome specific. Longitudinal history showed greater benefit for selected outcomes, whereas algorithm differences were modest and outcome dependent. The smaller MASLD signal was supported primarily by the pooled L1\u2013L2 analysis. Independent external validation is required before clinical application.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1964592","type":"journal-article","created":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:35:16Z","timestamp":1790915716000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Outcome-specific value of longitudinal clinical information and model complexity for dynamic prediction of type 2 diabetes-related outcomes: a pooled landmarking study"],"prefix":"10.3389","volume":"17","author":[{"given":"Meiling","family":"Fu","sequence":"first","affiliation":[{"name":"Shenzhen Hospital (Futian), Guangzhou University of Chinese Medicine, Guangdong","place":["Shenzhen, China"]},{"name":"The Sixth Clinical Medical College, Guangzhou University of Chinese Medicine, Guangdong","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohong","family":"Liu","sequence":"additional","affiliation":[{"name":"Shenzhen Hospital (Futian), Guangzhou University of Chinese Medicine, Guangdong","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Shi","sequence":"additional","affiliation":[{"name":"Shenzhen Hospital (Futian), Guangzhou University of Chinese Medicine, Guangdong","place":["Shenzhen, China"]},{"name":"The Sixth Clinical Medical College, Guangzhou University of Chinese Medicine, Guangdong","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxuan","family":"Lu","sequence":"additional","affiliation":[{"name":"Shenzhen Hospital (Futian), Guangzhou University of Chinese Medicine, Guangdong","place":["Shenzhen, China"]},{"name":"The Sixth Clinical Medical College, Guangzhou University of Chinese Medicine, Guangdong","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Zou","sequence":"additional","affiliation":[{"name":"Shenzhen Hospital (Futian), Guangzhou University of Chinese Medicine, Guangdong","place":["Shenzhen, China"]},{"name":"The Sixth Clinical Medical College, Guangzhou University of Chinese Medicine, Guangdong","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaowei","family":"Huang","sequence":"additional","affiliation":[{"name":"Shenzhen Hospital (Futian), Guangzhou University of Chinese Medicine, Guangdong","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingmei","family":"Pan","sequence":"additional","affiliation":[{"name":"Shenzhen Hospital (Futian), Guangzhou University of Chinese Medicine, Guangdong","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Chen","sequence":"additional","affiliation":[{"name":"Shenzhen Hospital (Futian), Guangzhou University of Chinese Medicine, Guangdong","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinqin","family":"Zhong","sequence":"additional","affiliation":[{"name":"Shenzhen Hospital (Futian), Guangzhou University of Chinese Medicine, Guangdong","place":["Shenzhen, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,10,2]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.2337\/dc26-S010","article-title":"10. Cardiovascular disease and risk management: Standards of care in diabetes-2026","volume":"49","year":"2026","journal-title":"Diabetes Care"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.2337\/dc26-S011","article-title":"11. Chronic kidney disease and risk management: Standards of care in diabetes-2026","volume":"49","year":"2026","journal-title":"Diabetes Care"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.2337\/dc26-S012","article-title":"12. Retinopathy, neuropathy, and foot care: Standards of care in diabetes-2026","volume":"49","year":"2026","journal-title":"Diabetes Care"},{"key":"B4","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","article-title":"EASL-EASD-EASO clinical practice guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"81","year":"2024","journal-title":"J Hepatol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1097\/HEP.0000000000000520","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"78","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"B6","doi-asserted-by":"publisher","first-page":"16","DOI":"10.3760\/cma.j.cn115791-20241203-00705","article-title":"Guideline for the prevention and treatment of diabetes mellitus in China (2024 edition)","volume":"17","year":"2025","journal-title":"Chin J Diabetes Mellitus"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn501113-20240327-00163","article-title":"Guidelines for the prevention and treatment of metabolic dysfunction-associated (non-alcoholic) fatty liver disease (Version 2024)","volume":"32","year":"2024","journal-title":"Chin J Hepatol"},{"key":"B8","doi-asserted-by":"publisher","first-page":"99","DOI":"10.3760\/cma.j.cn511434-20230110-00018","article-title":"Evidence-based guidelines for diagnosis and treatment of diabetic retinopathy in China (2022)","volume":"39","year":"2023","journal-title":"Chin J Ocul Fundus Dis"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2023.10.018","article-title":"KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"105","year":"2024","journal-title":"Kidney Int"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2022.110013","article-title":"Prediction of complications of type 2 diabetes: a machine learning approach","volume":"190","author":"Nicolucci","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1111\/jdi.14069","article-title":"Machine learning for the prediction of atherosclerotic cardiovascular disease during 3-year follow-up in Chinese patients with type 2 diabetes mellitus","volume":"14","author":"Ding","year":"2023","journal-title":"J Diabetes Investig"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1111\/dom.15745","article-title":"Development and validation of 10-year risk prediction models of cardiovascular disease in Chinese type 2 diabetes mellitus patients in primary care using interpretable machine learning-based methods","volume":"26","author":"Dong","year":"2024","journal-title":"Diabetes Obes Metab"},{"key":"B13","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1186\/s12967-022-03339-1","article-title":"Prediction of 3-year risk of diabetic kidney disease using machine learning based on electronic medical records","volume":"20","author":"Dong","year":"2022","journal-title":"J Transl Med"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2022.876559","article-title":"Using machine learning techniques to develop risk prediction models for the risk of incident diabetic retinopathy among patients with type 2 diabetes mellitus: a cohort study","volume":"13","author":"Zhao","year":"2022","journal-title":"Front Endocrinol"},{"key":"B15","doi-asserted-by":"publisher","first-page":"16741","DOI":"10.1038\/s41598-024-67533-5","article-title":"Development and external validation of a predictive model for type 2 diabetic retinopathy","volume":"14","author":"Li","year":"2024","journal-title":"Sci Rep"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.2196\/58107","article-title":"Development and validation of a machine learning algorithm for predicting diabetes retinopathy in patients with type 2 diabetes: algorithm development study","volume":"13","author":"Kim","year":"2025","journal-title":"JMIR Med Inform"},{"key":"B17","article-title":"Development of risk prediction models for hypertension comorbidity in community-dwelling patients with type 2 diabetes mellitus based on machine learning","volume":"24","author":"Li","year":"2025","journal-title":"Chin J Gen Pract"},{"key":"B18","doi-asserted-by":"publisher","first-page":"47","DOI":"10.13799\/j.cnki.mdjyxyxb.2024.03.015","article-title":"Construction, evaluation and validation of a risk prediction model for coronary heart disease in diabetes","volume":"45","author":"Xia","year":"2024","journal-title":"J Mudanjiang Med Univ"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.11958\/20231584","article-title":"Construction and verification of prediction model of type 2 diabetic nephropathy based on machine learning","volume":"52","author":"Wang","year":"2024","journal-title":"Tianjin Med J"},{"key":"B20","doi-asserted-by":"publisher","first-page":"696","DOI":"10.3760\/cma.j.cn115791-20240830-00519","article-title":"Study on influencing factors and predictive models of type 2 diabetes mellitus complicated with retinopathy","volume":"17","author":"Li","year":"2025","journal-title":"Chin J Diabetes Mellitus"},{"key":"B21","doi-asserted-by":"publisher","first-page":"741","DOI":"10.19485\/j.cnki.issn2096-5087.2024.09.002","article-title":"Prediction of non-alcoholic fatty liver in patients with type 2 diabetes mellitus","volume":"36","author":"Zheng","year":"2024","journal-title":"Prev Med"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1111\/dme.70398","article-title":"Comparative predictive accuracy of machine learning versus traditional statistical methods for diabetes-related complications: a systematic review and analysis","author":"Ghafoor","year":"2026","journal-title":"Diabetes Med"},{"key":"B23","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1111\/j.1467-9469.2006.00529.x","article-title":"Dynamic prediction by landmarking in event history analysis","volume":"34","author":"van Houwelingen","year":"2007","journal-title":"Scand J Stat"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1002\/sim.9336","article-title":"Landmarking 2.0: bridging the gap between joint models and landmarking","volume":"41","author":"Putter","year":"2022","journal-title":"Stat Med"},{"key":"B25","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s12874-022-01828-x","article-title":"Predicting the risk of a clinical event using longitudinal data: the generalized landmark analysis","volume":"23","author":"Yao","year":"2023","journal-title":"BMC Med Res Methodol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3760\/cma.j.cn112338-20210122-00051","article-title":"Introduction to the landmark model and its application in dynamic prediction","volume":"43","author":"Zhou","year":"2022","journal-title":"Chin J Epidemiol"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2023-078378","article-title":"TRIPOD+AI statement: updated guidance for reporting clinical prediction models that use regression or machine learning methods","volume":"385","author":"Collins","year":"2024","journal-title":"BMJ"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1136\/bmj-2024-082505","article-title":"PROBAST+AI: an updated quality, risk of bias, and applicability assessment tool for prediction models using regression or artificial intelligence methods","volume":"388","author":"Moons","year":"2025","journal-title":"BMJ"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.m441","article-title":"Calculating the sample size required for developing a clinical prediction model","volume":"368","author":"Riley","year":"2020","journal-title":"BMJ"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1111\/j.1467-9868.2005.00503.x","article-title":"Regularization and variable selection via the elastic net","volume":"67","author":"Zou","year":"2005","journal-title":"J R Stat Soc Ser B Stat Methodol"},{"key":"B31","article-title":"LightGBM: a highly efficient gradient boosting decision tree","volume-title":"Advances in Neural Information Processing Systems 30","author":"Ke","year":"2017"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-7-91","article-title":"Bias in error estimation when using cross-validation for model selection","volume":"7","author":"Varma","year":"2006","journal-title":"BMC Bioinf"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1002\/bimj.202200302","article-title":"Stability of clinical prediction models developed using statistical or machine learning methods","volume":"65","author":"Riley","year":"2023","journal-title":"Biom J"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1097\/EDE.0b013e3181c30fb2","article-title":"Assessing the performance of prediction models: a framework for traditional and novel measures","volume":"21","author":"Steyerberg","year":"2010","journal-title":"Epidemiology"},{"key":"B35","article-title":"A unified approach to interpreting model predictions","volume-title":"Advances in Neural Information Processing Systems 30","author":"Lundberg","year":"2017"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1177\/0272989X06295361","article-title":"Decision curve analysis: a novel method for evaluating prediction models","volume":"26","author":"Vickers","year":"2006","journal-title":"Med Decis Making"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pmed.0040296","article-title":"The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"4","author":"von Elm","year":"2007","journal-title":"PloS Med"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1111\/jch.14322","article-title":"A risk scoring system to predict the risk of new-onset hypertension among patients with type 2 diabetes","volume":"23","author":"Lin","year":"2021","journal-title":"J Clin Hypertens"},{"key":"B39","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1186\/s12933-024-02443-4","article-title":"External validation and calibration of risk equations for prediction of diabetic kidney diseases among patients with type 2 diabetes in Taiwan","volume":"23","author":"Su","year":"2024","journal-title":"Cardiovasc Diabetol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3390\/jcm14062065","article-title":"A machine learning-based prediction model for diabetic kidney disease in Korean patients with type 2 diabetes mellitus","volume":"14","author":"Lee","year":"2025","journal-title":"J Clin Med"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1016\/j.diabres.2025.112900","article-title":"A machine learning algorithm for the prediction of complications incorporated in electronic medical records improves type 2 diabetes care","volume":"229","author":"Nicolucci","year":"2025","journal-title":"Diabetes Res Clin Pract"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1111\/dom.15474","article-title":"Comparison of prediction models for cardiovascular and mortality risk in people with type 2 diabetes: an external validation in 23 685 adults included in the UK Biobank","volume":"26","author":"Zhang","year":"2024","journal-title":"Diabetes Obes Metab"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2901","article-title":"The impact of longitudinal data completeness of electronic health record data on the prediction performance of clinical risk scores","volume":"113","author":"Jin","year":"2023","journal-title":"Clin Pharmacol Ther"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1964592\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T04:35:43Z","timestamp":1790915743000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1964592\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,2]]},"references-count":43,"alternative-id":["10.3389\/fendo.2026.1964592"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1964592","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,2]]},"article-number":"1964592"}}